START / NEWS

Per Lundqvist appointed CEO at ONCOlog Medical AB

December 22, 2011

Göran Beijer has stepped down as CEO for ONCOlog Medical QA AB from December 19th and Per Lundqvist has been appointed new CEO. For more information contact Per Lundqvist, e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it. , phone: +46 733164904, or Stefan Sallerfors, e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it. , phone: +46 705907080.

 

ONCOlog Medical QA AB
Vallvägen 4B, SE-756 51, Uppsala, Sweden
PHONE: +46 18-19 45 65
FAX: +46 18-30 06 85
E-MAIL: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

 

 

 

CE Notified Body DGM, Denmark 0543 I ISO 13485:2003 International Standard specifies the quality system requirements for the design/development, production and, when relevant, installation and servicing of medical devices. CE Certificate Council Directive 93/42/EEC, Annex II, Section 3.2. Medical Device Directive. FDA. PatLog 1.0 FDA cleared 1/23/2009 K090044. PatLog 2.0 FDA cleared 10/9/2009 K092939. ONCOlog Medical registered for sale in the Russian territory.